CNX Therapeutics
Matthew Way is an experienced supply chain and logistics professional currently serving as the Supply Chain Director at CNX Therapeutics since January 2025. Prior roles include Director of Supply Chain and Operations at Porton Biopharma Ltd and Senior Vice President Supply Chain & Logistics at Tanner Pharma Group. Matthew has extensive experience in supply chain operations management, international procurement, contract management, and leadership, including significant contributions during tenure with the Australian and British Armies. Matthew holds a Master of Business Administration (MBA) from UNSW.
This person is not in any teams
This person is not in any offices
CNX Therapeutics
2 followers
CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We commercialise and distribute a portfolio of speciality brands and hospital products in Europe, in 40 countries worldwide, both directly and through strategic partnerships. Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.